Toms Capital Investment Management LP Viking Therapeutics, Inc. Transaction History
Toms Capital Investment Management LP
- $2.54 Billion
- Q3 2024
A detailed history of Toms Capital Investment Management LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Toms Capital Investment Management LP holds 763,600 shares of VKTX stock, worth $40.4 Million. This represents 1.61% of its overall portfolio holdings.
Number of Shares
763,600Holding current value
$40.4 Million% of portfolio
1.61%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding VKTX
# of Institutions
474Shares Held
66.2MCall Options Held
5.72MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$538 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$319 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$247 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$112 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$99.3 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.06B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...